+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Emergent BioSolutions, Inc. - logo

Emergent BioSolutions manufactures immunobiotics such as vaccines and immune globulins that assist the body’s immune system. The company’s biodefense segment develops drugs such as BioThrax, a vaccine for the prevention of anthrax, for use against biological agents. Other products in preclinical development include drugs for the treatment of patients exposed to anthrax and botulinum toxin. The company, which was founded in 1998, is based in Rockville, Maryland.

Mammalian Polyclonal IgG Antibody Market Size, Share & Trends Analysis Report By Type (Mouse, Rabbit), By Product (Cardiac, Metabolic), By Application (Western Blotting, ELISA), By End-user, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Mammalian Polyclonal IgG Antibody Market Size, Share & Trends Analysis Report By Type (Mouse, Rabbit), By Product (Cardiac, Metabolic), By Application (Western Blotting, ELISA), By End-user, And Segment Forecasts, 2023 - 2030

  • Report
  • February 2023
  • 180 Pages
  • Global
From
Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.) Financial Analysis, Market Size & Benchmarks, and Revenue Forecasts to 2032 with P&L, KPIs, and EBITDA - Product Thumbnail Image

Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.) Financial Analysis, Market Size & Benchmarks, and Revenue Forecasts to 2032 with P&L, KPIs, and EBITDA

  • Report
  • December 2025
  • 108 Pages
  • United States
From
United States Vaccines Market Size, Top 47 Vaccines Brand In-depth Analysis, Insights, and Forecasts to 2033 - Product Thumbnail Image

United States Vaccines Market Size, Top 47 Vaccines Brand In-depth Analysis, Insights, and Forecasts to 2033

  • Report
  • May 2025
  • 230 Pages
  • United States
From
Shigellosis - Pipeline Insight, 2025 - Product Thumbnail Image

Shigellosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Prefilled Syringe Fill Finish Manufacturing Market: Industry Trends and Global Forecasts - Distribution by Type of Therapeutic Area, Type of Syringe Barrel Material, Number of Barrel Chambers, Type of Drug Molecule, Scale of Operation and Key Geographical Regions - Product Thumbnail Image

Prefilled Syringe Fill Finish Manufacturing Market: Industry Trends and Global Forecasts - Distribution by Type of Therapeutic Area, Type of Syringe Barrel Material, Number of Barrel Chambers, Type of Drug Molecule, Scale of Operation and Key Geographical Regions

  • Report
  • December 2025
  • 267 Pages
  • Global
From
Biodefense Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Biodefense Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Influenza Vaccines Market, Persons Vaccinated, By Segment - Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032) - Product Thumbnail Image

Influenza Vaccines Market, Persons Vaccinated, By Segment - Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032)

  • Report
  • January 2025
  • 388 Pages
  • Global
From
Preventable Vaccines - Global Strategic Business Report 2026 - Product Thumbnail Image

Preventable Vaccines - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 391 Pages
  • Global
From
Inactivated Vaccines - Global Strategic Business Report - Product Thumbnail Image

Inactivated Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 468 Pages
  • Global
From
Ebola Virus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Ebola Virus Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 336 Pages
  • Global
From
Oral Typhoid Vaccines - Global Strategic Business Report - Product Thumbnail Image

Oral Typhoid Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 183 Pages
  • Global
From
Bacterial Vaccines - Global Strategic Business Report - Product Thumbnail Image

Bacterial Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 490 Pages
  • Global
From
Adult Vaccines - Global Strategic Business Report - Product Thumbnail Image

Adult Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 377 Pages
  • Global
From
Adenovirus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Adenovirus Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 279 Pages
  • Global
From
Respiratory Virus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Respiratory Virus Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 474 Pages
  • Global
From
Digital Vaccines - Global Strategic Business Report - Product Thumbnail Image

Digital Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 274 Pages
  • Global
From
Multivalent Vaccines - Global Strategic Business Report - Product Thumbnail Image

Multivalent Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 278 Pages
  • Global
From
Ebola Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Ebola Drugs and Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 485 Pages
  • Global
From
Typhoid Fever Vaccines - Global Strategic Business Report - Product Thumbnail Image

Typhoid Fever Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 372 Pages
  • Global
From
Toxoid Vaccines - Global Strategic Business Report - Product Thumbnail Image

Toxoid Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 282 Pages
  • Global
From
Loading Indicator